4.7 Article

Identification of miR-20a-5p as Robust Normalizer for Urine microRNA Studies in Renal Cell Carcinoma and a Profile of Dysregulated microRNAs

相关参考文献

注意:仅列出部分参考文献,下载原文获取全部文献信息。
Review Oncology

Circulating Cell-Free DNA in Liquid Biopsies as Potential Biomarker for Bladder Cancer: A Systematic Review

Raquel Herranz et al.

Summary: Bladder cancer is a common and deadly cancer type, with current diagnostic and treatment methods being costly and invasive. Cell-free DNA has been identified as a potential biomarker for diagnosing and monitoring treatment effectiveness in bladder cancer.

CANCERS (2021)

Review Biochemistry & Molecular Biology

Targeting AKT/mTOR in Oral Cancer: Mechanisms and Advances in Clinical Trials

Choudhary Harsha et al.

INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2020)

Article Urology & Nephrology

Urinary microRNAs: Looking for a New Tool in Diagnosis, Prognosis, and Monitoring of Renal Cancer

Julia Oto et al.

CURRENT UROLOGY REPORTS (2020)

Article Biochemistry & Molecular Biology

Identification of miR-29c-3p as a Robust Normalizer for Urine microRNA Studies in Bladder Cancer

Julia Oto et al.

BIOMEDICINES (2020)

Review Oncology

Epidemiology of Renal Cell Carcinoma

Sandeep Anand Padala et al.

WORLD JOURNAL OF ONCOLOGY (2020)

Review Oncology

The power of microRNAs as diagnostic and prognostic biomarkers in liquid biopsies

Lorena Quirico et al.

CANCER DRUG RESISTANCE (2020)

Review Biochemistry & Molecular Biology

Targeting PI3K in cancer: mechanisms and advances in clinical trials

Jing Yang et al.

MOLECULAR CANCER (2019)

Article Cell Biology

Urinary exosome miR-30c-5p as a biomarker of clear cell renal cell carcinoma that inhibits progression by targeting HSPA5

Shangqing Song et al.

JOURNAL OF CELLULAR AND MOLECULAR MEDICINE (2019)

Review Urology & Nephrology

MicroRNAs as biomarkers in chronic kidney disease

Alexa Wonnacott et al.

CURRENT OPINION IN NEPHROLOGY AND HYPERTENSION (2017)

Article Oncology

The utility of urine-circulating miRNAs for detection of prostate cancer

Kristina Stuopelyte et al.

BRITISH JOURNAL OF CANCER (2016)

Review Oncology

OncomiR or Tumor Suppressor? The Duplicity of MicroRNAs in Cancer

Alexander A. Svoronos et al.

CANCER RESEARCH (2016)

Review Urology & Nephrology

The translational potential of microRNAs as biofluid markers of urological tumours

Annika Fendler et al.

NATURE REVIEWS UROLOGY (2016)

Review Medical Laboratory Technology

Data Normalization Strategies for MicroRNA Quantification

Heidi Schwarzenbach et al.

CLINICAL CHEMISTRY (2015)

Review Obstetrics & Gynecology

PI3K/AKT/mTOR signaling pathway as a therapeutic target for ovarian cancer

HaiXia Li et al.

ARCHIVES OF GYNECOLOGY AND OBSTETRICS (2014)

Review Transplantation

MicroRNAs in kidney diseases: new promising biomarkers for diagnosis and monitoring

F. P. Schena et al.

NEPHROLOGY DIALYSIS TRANSPLANTATION (2014)

Review Oncology

Targeting PI3K/Akt/mTOR signaling in cancer

Camillo Porta et al.

FRONTIERS IN ONCOLOGY (2014)

Article Oncology

Renal cell carcinoma

Paul Cairns

CANCER BIOMARKERS (2011)

Article Urology & Nephrology

Accurate Molecular Classification of Kidney Cancer Subtypes Using MicroRNA Signature

Youssef M. Youssef et al.

EUROPEAN UROLOGY (2011)

Article Pathology

Accurate Molecular Classification of Renal Tumors Using MicroRNA Expression

Eddie Fridman et al.

JOURNAL OF MOLECULAR DIAGNOSTICS (2010)

Review Biochemistry & Molecular Biology

MicroRNAs: Target Recognition and Regulatory Functions

David P. Bartel

Article Urology & Nephrology

Prognostic role of the histologic subtypes of renal cell carcinoma after slide revision

Vincenzo Ficarra et al.

EUROPEAN UROLOGY (2006)